Zobrazeno 1 - 10
of 109
pro vyhledávání: '"Ion Cristóbal"'
Autor:
Cristina Caramés, Javier Arcos, Bernadette Pfang, Ion Cristóbal, Juan Antonio Álvaro de la Parra
Publikováno v:
Frontiers in Public Health, Vol 12 (2024)
Controversy surrounds the current debate regarding the effects of outsourcing health services, as recent studies claim that increased outsourcing leads to reduced costs at the expense of worse patient outcomes. The goal of the value-based model is to
Externí odkaz:
https://doaj.org/article/3614f19876ef4333837150b7d0209b18
Autor:
Iván Prieto-Potin, Franklin Idrovo, Ana Suárez-Gauthier, María Díaz-Blázquez, Laura Astilleros-Blanco de Córdova, Cristina Chamizo, Sandra Zazo, Nerea Carvajal, Almudena López-Sánchez, Sandra Pérez-Buira, Carmen Laura Aúz-Alexandre, Rebeca Manso, Jenifer Plaza-Sánchez, Virginia de Lucas-López, Nuria Pérez-González, Sara Martín-Valle, Ion Cristóbal, Victoria Casado, Jesús García-Foncillas, Federico Rojo
Publikováno v:
Diagnostics, Vol 12, Iss 8, p 1903 (2022)
Gynecological cancer accounts for an elevated incidence worldwide requiring responsiveness regarding its care. The comprehensive genomic approach agrees with the classification of certain tumor types. We evaluated 49 patients with gynecological tumor
Externí odkaz:
https://doaj.org/article/5997035934bb459c94fd59bc4cba53f2
Autor:
Iván Prieto-Potin, Nerea Carvajal, Jenifer Plaza-Sánchez, Rebeca Manso, Carmen Laura Aúz-Alexandre, Cristina Chamizo, Sandra Zazo, Almudena López-Sánchez, Socorro María Rodríguez-Pinilla, Laura Camacho, Raquel Longarón, Beatriz Bellosillo, Rosa Somoza, Javier Hernández-Losa, Víctor Manuel Fernández-Soria, Ricardo Ramos-Ruiz, Ion Cristóbal, Jesús García-Foncillas, Federico Rojo
Publikováno v:
PeerJ, Vol 8, p e10069 (2020)
Background Next-generation sequencing (NGS) is a high-throughput technology that has become widely integrated in molecular diagnostics laboratories. Among the large diversity of NGS-based panels, the Trusight Tumor 26 (TsT26) enables the detection of
Externí odkaz:
https://doaj.org/article/6a82bc40e8c845f88d8f03973d27e115
Autor:
Rebeca Manso, Nerea Martínez-Magunacelaya, Itziar Eraña-Tomás, Verónica Monsalvez, José L Rodríguez-Peralto, Pablo-L Ortiz-Romero, Carlos Santonja, Ion Cristóbal, Miguel A Piris, Socorro M Rodríguez-Pinilla
Publikováno v:
PLoS ONE, Vol 13, Iss 6, p e0198477 (2018)
Differentiating early mycosis fungoides (MF) from inflammatory dermatitis is a challenge. We compare the differential expression profile of early-stage MF samples and benign inflammatory dermatoses using microRNA (miRNA) arrays. 114 miRNAs were found
Externí odkaz:
https://doaj.org/article/750299082c9f4438b8dfc7fb7e6985de
Autor:
Ion Cristóbal, Paula González-Alonso, Lina Daoud, Esther Solano, Blanca Torrejón, Rebeca Manso, Juan Madoz-Gúrpide, Federico Rojo, Jesús García-Foncillas
Publikováno v:
Marine Drugs, Vol 13, Iss 6, Pp 3276-3286 (2015)
Protein phosphatase 2A (PP2A) is a tumor suppressor complex that has recently been reported as a novel and highly relevant molecular target in prostate cancer (PCa). However, its potential therapeutic value remains to be fully clarified. We treated P
Externí odkaz:
https://doaj.org/article/fc737634dcf647f3b92be0eba3f1b1f6
Autor:
Ion Cristóbal, Cristina Cirauqui, Remedios Castello-Cros, Laura Garcia-Orti, María J. Calasanz, María D. Odero
Publikováno v:
Haematologica, Vol 98, Iss 9 (2013)
Externí odkaz:
https://doaj.org/article/ad750debfbed4d498610318b898e71c5
Autor:
Ion Cristóbal, Laura Garcia-Orti, Cristina Cirauqui, Xabier Cortes-Lavaud, María A. García-Sánchez, María J. Calasanz, María D. Odero
Publikováno v:
Haematologica, Vol 97, Iss 4 (2012)
Background Protein phosphatase 2A is a novel potential therapeutic target in several types of chronic and acute leukemia, and its inhibition is a common event in acute myeloid leukemia. Upregulation of SET is essential to inhibit protein phosphatase
Externí odkaz:
https://doaj.org/article/e54276983d09407095241492c50335fc
Autor:
Laura García-Ortí, Ion Cristóbal, Cristina Cirauqui, Elisabet Guruceaga, Nerea Marcotegui, María J Calasanz, Remedios Castello-Cros, María D Odero
Publikováno v:
PLoS ONE, Vol 7, Iss 10, p e47717 (2012)
BACKGROUND: Deregulated miRNA expression plays a crucial role in carcinogenesis. Recent studies show different mechanisms leading to miRNA deregulation in cancer; however, alterations affecting miRNAs by DNA copy number variations (CNV) remain poorly
Externí odkaz:
https://doaj.org/article/82d0dc2d742f45149ce389297d4f13c0
Autor:
Jesús García-Foncillas, Federico Rojo, Juan Madoz-Gúrpide, Oscar Aguilera, Sandra Zazo, María Rodriguez, Javier Martínez-Useros, Aurea Borrero, Clara Senin, Cristina Caramés, Raúl Rincón, Rebeca Manso, Ion Cristóbal
PDF - 124K, Supplementary Table 1. Clinical and molecular characteristics of the 21 patients with CRC included in the study. Supplementary Table 2. Analysis of PP2A activity levels using 1D6 or FL-309 antibodies, SET overexpression, CIP2A overexpress
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8da5d05fd028477acdfd7b8ffda15229
https://doi.org/10.1158/1535-7163.22499598
https://doi.org/10.1158/1535-7163.22499598
Autor:
Federico Rojo, Juan Madoz-Gúrpide, Ana Rovira, Joan Albanell, Jesús García-Foncillas, Pilar Eroles, Ana Lluch, Rosario Perona, Carmen Cañadas, Ion Cristóbal, Ester Martín-Aparicio, Paula González-Alonso, Rebeca Manso, Cristina Chamizo, Sandra Zazo, Raúl Rincón
Supplementary Figure S1. MKP-1 protein abundance levels in MDA-MB-231 cells treated with docetaxel at progressively increasing times. Supplementary Figure S2. Cell growth in the presence of the docetaxel or doxorubicin of breast cancer cell lines ove
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49f9f3360e9d15474b0bfdd5d4c07d6b
https://doi.org/10.1158/1535-7163.22506093
https://doi.org/10.1158/1535-7163.22506093